Startseite>>Signaling Pathways>> Metabolism>> Cofactors & Vitamins>>G6PDi-1

G6PDi-1 (Synonyms: Glucose-6-phosphate Dehydrogenase Inhibitor 1)

Katalog-Nr.GC47387

G6PDi-1 ist ein reversibler und nicht kompetitiver Glucose-6-Phosphat-Dehydrogenase (G6PD)-Inhibitor mit einem IC50von 0,07μM.

Products are for research use only. Not for human use. We do not sell to patients.

G6PDi-1 Chemische Struktur

Cas No.: 2457232-14-1

Größe Preis Lagerbestand Menge
1 mg
58,00 $
Auf Lager
5 mg
158,00 $
Auf Lager
10 mg
327,00 $
Auf Lager
25 mg
505,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

G6PDi-1 is a reversible and noncompetitive inhibitor of glucose-6-phosphate dehydrogenase (G6PDH; IC50 = 0.07 µM), the enzyme that converts G6P to 6-phosphogluconolactone using NADP+ as a cofactor in the first step of the pentose phosphate pathway.1 G6PDi-1 (10 and 50 µM) reduces NADPH levels in a variety of cultured cells, including red blood cells and T cells. It decreases colony formation of HCT116 cells when used at concentrations of 20 and 30 µM, an effect that can be rescued by the antioxidant N-acetyl cysteine. G6PDi-1 decreases the production of cytokines induced by phorbol 12-myristate 13-acetate and ionomycin in T cells and prevents PMA-induced oxidative burst in neutrophils.

1.Ghergurovich, J.M., GarcÍa-CaÑaveras, J.C., Wang, J., et al.A small molecule G6PD inhibitor reveals immune dependence on pentose phosphate pathwayNat. Chem. Biol.16(7)731-739(2020)

Bewertungen

Review for G6PDi-1

Average Rating: 5 ★★★★★ (Based on Reviews and 9 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for G6PDi-1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.